Dr. Aysegul Soyer, M.D.

Media Releases

Get to know Neurologist Dr. Aysegul Soyer, who serves patients in Woodbridge, Virginia.

Fluent in English, German, Spanish, and Turkish, Dr. Soyer is a board-certified neurologist who is affiliated with Sentara Northern Virginia Medical Center in Woodbridge, Virginia. 

Sentara Northern Virginia Medical Center is a 183-bed, not-for-profit hospital that offers the resources of a major health system combined with the compassionate, personalized care of a community hospital. Offering a wide range of medical specialties, a highly qualified medical and clinical staff, and state-of-the-art technology, the comprehensive services of Sentara Northern Virginia Medical Center include primary care, emergency care, advanced imaging, cancer, diabetes, heart and vascular, orthopedics, urology, weight loss surgery, and women’s services.

In 1980, Dr. Soyer earned her Medical Degree from the Istanbul University Faculty of Medicine. She then went on to complete her residency in neurology at Drexel University College of Medicine in Philadelphia, Pennsylvania. 

Following her education, she became board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to promoting high quality patient care for the public through the initial and continuing certification of psychiatrists and neurologists. 

Additionally, the doctor remains a member of several professional organizations, including the American Academy of Neurology and the Medical Society of Northern Virginia. 

Neurology is a branch of medicine dealing with disorders of the nervous system. It deals with the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous systems, including their coverings, blood vessels, and all effector tissue, such as muscle. Neurologists are medical specialists who diagnose and treat disorders that affect the brain, spinal cord, nerves, and muscles of patients. They examine a patient’s mental and physical status, conduct medical tests and scans, and evaluate the results to diagnose and treat the patient. 

Recommended Articles

• CRISPR Could be the Possible Cure for Muscular Dystrophy

  How about technology that could offer a “cut and paste” or just a “delete” solution to all genetic mutations, defects, and resulting disorders? Well, that may sound too much to ask for, an oversimplification, but it is exactly what many scientific researchers in the field of genetic modeling...

• Support Groups for Muscular Dystrophy: Finding Genuine Connection and Understanding

  A lot of people are suffering from muscular dystrophy (MD). The most common forms of MD in children are Duchenne and Becker, and about 400 to 500 boys are born with these in the United States each year. About 70,000 people in the UK suffer from MD. This condition, which is usually acquired by people...

• Leptomeningeal Disease: When Breast Cancer Metastasize to the Brain

  Introduction When breast cancer cells spread to the brain, it is called as brain metastases or secondary breast cancer. It is also known as metastatic breast cancer, advanced breast cancer, secondary or stage four breast cancer, or secondary tumor. When cancer cells reach the brain, it cannot be...

• What Is Neuropathy?

  Disorders that arise due to peripheral nervous system damage are referred to as peripheral neuropathy or simply neuropathy. Peripheral nerves are the nerves that connect the brain and spinal cord to different parts of the body. These nerves innervate different organs of our body, including the skin,...

• Medical Marijuana for Multiple Sclerosis Symptoms

  Multiple sclerosis experts in the UK say that people with the disease should be permitted to use cannabis to relieve their symptoms. The experts suggest that over nine thousand people should be allowed to use the drug.The MS Society states that one in ten multiple sclerosis patients have pain and...

• Blocking Enzymes May Be the Key to Alzheimer's Treatment

  Scientists at the Massachusetts Institute of Technology (MIT) have been working on a potential new treatment for Alzheimer’s disease. They are honing in on the genetics involved, hoping to hijack enzymes to do the job.There are genes that turn on to help us make new memories.It’s been shown in...